Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Mathai

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Journal of Affective Disorders|May 17, 2026
Interdisciplinary, delphi-driven consensus guidelines on the use of intravenous ketamine infusions for depressive disorders from the American society of ketamine physicians, psychotherapists, and practitioners (ASKP3)David S Mathai, Madeleine Cluck, Amna M Aslam, et al.
Harm Reduction Journal|December 31, 2025
US drug policy does not align with experts' rankings of drug harms: a multi-criteria decision analysisMichael Broman, Alan K Davis, Stacey Armstrong, et al.
Psychiatric Research and Clinical Practice|April 2, 2025
On Minimizing Risk and Harm in the Use of PsychedelicsJules Evans, Marc Aixalà, Brian T Anderson, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Journal of Affective Disorders|May 17, 2026
Interdisciplinary, delphi-driven consensus guidelines on the use of intravenous ketamine infusions for depressive disorders from the American society of ketamine physicians, psychotherapists, and practitioners (ASKP3)David S Mathai, Madeleine Cluck, Amna M Aslam, et al.
Harm Reduction Journal|December 31, 2025
US drug policy does not align with experts' rankings of drug harms: a multi-criteria decision analysisMichael Broman, Alan K Davis, Stacey Armstrong, et al.
Psychiatric Research and Clinical Practice|April 2, 2025
On Minimizing Risk and Harm in the Use of PsychedelicsJules Evans, Marc Aixalà, Brian T Anderson, et al.
Pageof 3